Prakt. lékáren. 2014; 10(5): 166-170

The Oxford League Table of Analgesic Efficacy and Acute Pain Therapy from the Pharmacist’s Point of View

Martin Šimíček
Nemocniční lékárna FN u sv. Anny v Brně

Analgesics are one of the mostly used types of medications. The Oxford League Table of Analgesic Efficacy is commented in the following

article as a useful tool for choice of suitable analgesic regarding its efficiency, safety and correct dosage. There are commented

the therapeutic indications, contraindications and adverse effects of individual analgesic types regarding the possibility of their usage

in patients’ self-treatment.

Keywords: analgesics, the Oxford league table of analgesic efficacy, over-the-counter drugs

Published: October 24, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šimíček M. The Oxford League Table of Analgesic Efficacy and Acute Pain Therapy from the Pharmacist’s Point of View. Farmacie pro praxi. 2014;10(5):166-170.
Download citation

References

  1. Goněc R, Kozáková Š. Léčba bolesti volně prodejnými léčivými přípravky, Prakt. lékáren. 2012; 8(2): 90-92.
  2. i-CLB - informačně edukační portál pro veřejnost, dostupné z www: http://www.i-clb.cz/cs/prakticka-doporuceni/[cit.2014-06-12].
  3. Nosková P. Jak zvládnout rychle bolest. Interní Med. 2011; 13(9): 360-364.
  4. Souhrnné údaje o dodávkách léčivých přípravků do lékáren a jiných zdravotnických zařízení dle léčivé látky a cesty podání. Dostupné z www: http://www.sukl.cz/rok-20141 [cit. 2014-06-12].
  5. Oxfordská liga analgetik. Dostupné z www: http://www.medicine.ox.ac.uk/bandolier/booth/painpag/acutrev/analgesics/leagtab.html [cit. 2014-06-12].
  6. Moore RA, Derry S, McQuay HJ, Wiffen PJ. Single dose oral analgesics for acute postoperative pain in adults. Cochrane Database Syst Rev. 2011 Sep 7; (9). Go to original source... Go to PubMed...
  7. McQuay HJ, Derry S, Eccleston C, Wiffen PJ, Andrew Moore R: Evidence for analgesic effect in acute pain - 50 years on. Pain 2012; 153(7): 1364-1367. Go to original source... Go to PubMed...
  8. Moore RA, Straube S, Paine J, Derry S, McQuay HJ. Minimum efficacy criteria for comparisons between treatments using individual patient meta-analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen/paracetamol combinations after third molar extraction. Pain 2011; 152: 982-989. Go to original source... Go to PubMed...
  9. Kršiak M. Jak zvýšit analgetickou účinnost paracetamolu? Interní medicína pro praxi 2011; 13(3).
  10. Kršiak M. Žádoucí interakce analgetik, Praktické lékárenství 1/2006: 15-17.
  11. Vetchý D. Panadol novum - technologie Optizorb. Dostupné z www: http://www.edukafarm.cz/data/soubory/casopisy/19/56_optizorb.pdf. [cit. 2014-06-12].
  12. Hedenmalm K, Spigset O. Agranulocytosis and other blood dyscrasias associated with dipyrone(metamizole). European Journal of Clinical Pharmacology 2002; 58: 265-274. Go to original source... Go to PubMed...
  13. Hakl M. Arcoxia a její pozice v léčbě akutní bolesti. New EU Magazine of Medicine 2011; 3-4: 27-29.
  14. Vítovec J, Gregor P. Koxiby a kardiovaskulární riziko. Remedia 2005; 15: 158-162.
  15. Coxib and traditional NSAIDs Trialists Collaboration. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013. doi: 10.1016/S0140-6736(13)60900-9. [cit. 2014-06-12]. Go to original source... Go to PubMed...
  16. Fojtík Z. Použití aceklofenaku v revmatologické praxi. Medical Tribune 2012; 23.
  17. Hakl M. Novinky v terapii bolesti. Klin Farmakol Farm 2012; 26(2): 102-105.
  18. Olejárová M. Lokální nesteroidní antirevmatika v revmatologii. Praktické lékárenství 2008; 4(2): 74-78.
  19. www.jr2.ox.ac.uk/bandolier/painres/topic/topic.html [cit. 2014-06-12].
  20. Doležal T, Hakl M, Kozák J, Kršiak M, Lejčko J, Skála B, Sláma O, Ševčík P, Vorlíček J. Metodické pokyny pro farmakoterapii akutní a chronické nenádorové bolesti SSLB update 2009.




Pharmacy for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.